CEO's On the Move
High Peak Royalties Limited Appoints Simon Fyfe as Chief Executive Officer, Effective September 3, 2015
High Peak Royalties Limited
:Australian Stock Exchange - SEATS) High Peak Royalties Limited announced the appointment of Simon Fyfe as Chief Executive Officer, as from September 03, 2015 subject to the terms and conditions of a conventional executive service agreement. Mr. Fyfe has a Bachelor of Business and Graduate Diploma of Applied Finance and Investment. Since ...
Upcoming Board Meetings
September 3, 2015
IZMO Limited, Board Meeting, Sep 03, 2015. Agenda: To consider adoption of directors report 2015; to consider convening 20th annual general meeting and authorizing issue, and publication of notice of AGM; to approve resignation of company secretary; and to approve finalization of date of book closure.
IZMO Limited Key Board Members
Chairperson, Member of Audit Committee, Member of Remuneration Committee and Member o...
Co-Founder, Managing Director, Director and Chairman of Share Transfer Committee
Independent Non-Executive Director, Chairman of Audit Committee and Chairman of Remun...
Hargreaves Services plc Appoints Nigel Halkes to the Board as Independent Non-Executive Director and Chairman Designate of the Audit Committee
Hargreaves Services plc announced the appointment of Nigel Halkes to the board as an independent non-executive director and chairman designate of the audit committee. Nigel is a former managing partner of Ernst and Young, UK & Ireland. He has considerable FTSE 100 experience, acting as a global client service partner for a number of major clients, including Rio Tinto plc, Centrica plc and BT Group. Nigel also gained valuable experience acting as audit partner for British Coal for ten years. He is a Founding Trustee of the charitable EY Foundation.
C4X Discovery Holdings plc Announces New Appointments
C4X Discovery Holdings plc announced that it is further strengthening its team with two new management appointments. Dr. Craig Fox joins the company as Head of Biology and a member of the Senior Management Team. Dr. Fox is an experienced biologist having worked on and managed many drug discovery and development projects during the last 18 years, from initial target selection right through to investigating clinical efficacy and safety in Phase II patient studies. Prior to joining C4XD, Dr. Fox was Director of Respiratory Research at Pulmagen Therapeutics, a clinical stage company spun-out of Argenta in 2010. Dr. Clare Murray joins the Company as Project Manager. Dr. Murray spent 23 years with AstraZeneca, where she was most recently Associate Director, Bioscience, within the Emerging Innovations Unit. Whilst at AstraZeneca, Dr. Murray led biology, pharmacology and clinical development teams up to Phase II across a range of therapeutic areas including respiratory, inflammation, dermatitis and oncology.
BDO Leasing and Finance, Inc Announces Resignation of angelita L. Ortega-Cortez as Assistant Corporate Secretary and Alternate Corporate Information Officer, Effective October 1, 2015
The Board of Directors of BDO Leasing and Finance, Inc., at its regular meeting held on September 2, 2015, accepted the resignation of Atty. angelita L. Ortega-Cortez as Assistant Corporate Secretary and Alternate Corporate Information Officer, effective October 1, 2015.